Stockscreener 앱 받기
1.825
1.94%
0.035
Coherus Oncology Inc 주식(CHRS)의 최신 뉴스
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - Yahoo! Finance Canada
Coherus Oncology (CHRS) to Release Q1 2026 Financial Results - GuruFocus
Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 - The Manila Times
Coherus sets May 11 after-close call for Q1 results, business update - Stock Titan
Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Hepatic Tumor Pipeline Grows as 75+ Pharma Companies Advance - openPR.com
Satterfield reports 6.93M shares in Coherus Oncology (NASDAQ: CHRS) ownership filing - Stock Titan
BlackRock reports 4.9% stake in Coherus Oncology (CHRS) - Stock Titan
Coherus Oncology announces proposed public offering of common stock - MSN
Coherus Oncology (NASDAQ:CHRS) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
CHRS Price Today: Coherus Oncology, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Coherus Oncology prices stock offering to raise $50.1M - MSN
Is Coherus (CHRS) stock losing upward momentum (Bullish Sentiment) 2026-04-20Crowd Sentiment Stocks - Cổng thông tin điện tử tỉnh Lào Cai
[ARS] Coherus Oncology, Inc. SEC Filing - Stock Titan
[DEF 14A] Coherus Oncology, Inc. Definitive Proxy Statement - Stock Titan
Coherus (CHRS) Stock Signal Based Trade (Bullish Momentum) 2026-04-16Professional Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Coherus Oncology (CHRS) is one of the best penny stocks, here is why – corrected - MSN
Coherus Oncology Inc (STU:8C5) Stock Price & 30 Year Financial Data - GuruFocus
Certain Warrants of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com
Certain Stock Options of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com
Certain Common Stock of Coherus Oncology, Inc. are subject to a Lock-Up Agreement Ending on 14-APR-2026. - marketscreener.com
CHRS SEC FilingsCoherus 10-K, 10-Q, 8-K Forms - Stock Titan
What should investors watch in Coherus (CHRS) Stock | Price at $1.66, Down 1.49%Trader Community Insights - Xã Vĩnh Công
Coherus Oncology (CHRS) Is One of the Best Penny Stocks, Here is Why – Corrected - Yahoo Finance
Coherus Oncology (CHRS) proposes option repricing and 7.7M-share increase - Stock Titan
Coherus Oncology Receives 'Hold' Rating from Analysts - National Today
Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Coherus Oncology (NASDAQ:CHRS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Why The Coherus Oncology (CHRS) Story Is Shifting Around Growth Assumptions And Execution Risk - Yahoo Finance
Coherus Oncology (CHRS) upgraded to buy: Here's what you should know - msn.com
Vanguard disaggregates holdings; 0% stake in Coherus (NASDAQ: CHRS) - Stock Titan
If You Invested $1,000 in Coherus (CHRS) - Stock Titan
Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline - openpr.com
Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Coherus Oncology (NASDAQ:CHRS) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
CHRS Technical Analysis & Stock Price Forecast - Intellectia AI
Coherus BioSciences Q4 2025 earnings preview - MSN
Coherus Oncology (CHRS) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Coherus Oncology Pivots to Immuno-Oncology, Touts LOQTORZI Growth and New Pipeline at Citizens Conf. - MarketBeat
Coherus Oncology (NASDAQ:CHRS) Upgraded at Wall Street Zen - MarketBeat
Coherus Oncology, Inc. (NASDAQ:CHRS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Coherus Oncology (CHRS) price target increased by 13.33% to 5.78 - MSN
0.78%
3.01%
자본화:
|
볼륨(24시간):